Key facts
- This page summarizes C. David Brown II's Form 4 filing for CVS HEALTH Corp (CVS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 25 Nov 2024, 17:38.
C. David Brown II - 21 Nov 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)
- Reporting relationship
- Director
- Issuer ticker
- CVS
- Reported as of
- 21 Nov 2024
- Net transaction value
- +$133,100
- SEC form
- 4
- Accepted by SEC
- 25 Nov 2024, 17:38:01 UTC
- Prior SEC filing
- 17 May 2024
- Next SEC filing
- 19 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ C. David Brown II
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
C. David Brown II filed Form 4 for CVS HEALTH Corp (CVS) on 25 Nov 2024.
Change
- Previous filing in this sequence was filed on 17 May 2024.
- Current net transaction value: +$133,100.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CVS
transaction
Common Stock
Award
- Transaction value
- $133,100
- Shares
- +2,331
- Change %
- +1.9%
- Price
- $57.10
- Shares after
- 123,765
- Date
- 21 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CVS
holding
Derivative
Share Credits
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 81,978
- Date
- 21 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 81,978
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
Footnote F2
Consists of deferred stock compensation payable pursuant to Reporting Person's election.